308 related articles for article (PubMed ID: 18336192)
1. Targeting cell death in tumors by activating caspases.
MacKenzie SH; Clark AC
Curr Cancer Drug Targets; 2008 Mar; 8(2):98-109. PubMed ID: 18336192
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy.
Putt KS; Chen GW; Pearson JM; Sandhorst JS; Hoagland MS; Kwon JT; Hwang SK; Jin H; Churchwell MI; Cho MH; Doerge DR; Helferich WG; Hergenrother PJ
Nat Chem Biol; 2006 Oct; 2(10):543-50. PubMed ID: 16936720
[TBL] [Abstract][Full Text] [Related]
3. Targeting apoptotic caspases in cancer.
Boice A; Bouchier-Hayes L
Biochim Biophys Acta Mol Cell Res; 2020 Jun; 1867(6):118688. PubMed ID: 32087180
[TBL] [Abstract][Full Text] [Related]
4. Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine.
Miles MA; Hawkins CJ
Cell Death Dis; 2017 Oct; 8(10):e3062. PubMed ID: 28981092
[TBL] [Abstract][Full Text] [Related]
5. Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cells.
Zaman S; Wang R; Gandhi V
Exp Hematol; 2015 Nov; 43(11):951-962.e3. PubMed ID: 26257207
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
[TBL] [Abstract][Full Text] [Related]
7. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic activation of caspases in cancer: a question of selectivity.
Beauparlant P; Shore GC
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):179-87. PubMed ID: 12669453
[TBL] [Abstract][Full Text] [Related]
9. Caspase activity modulators as anticancer agents.
Okun I; Balakin KV; Tkachenko SE; Ivachtchenko AV
Anticancer Agents Med Chem; 2008 Apr; 8(3):322-41. PubMed ID: 18393791
[TBL] [Abstract][Full Text] [Related]
10. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions.
Ashkenazi A
J Clin Invest; 2015 Feb; 125(2):487-9. PubMed ID: 25642709
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
Oyarzo MP; Drakos E; Atwell C; Amin HM; Medeiros LJ; Rassidakis GZ
Hum Pathol; 2006 Jul; 37(7):874-82. PubMed ID: 16784988
[TBL] [Abstract][Full Text] [Related]
12. Synthetic triterpenoid cyano enone of methyl boswellate activates intrinsic, extrinsic, and endoplasmic reticulum stress cell death pathways in tumor cell lines.
Ravanan P; Sano R; Talwar P; Ogasawara S; Matsuzawa S; Cuddy M; Singh SK; Rao GS; Kondaiah P; Reed JC
Mol Cancer Ther; 2011 Sep; 10(9):1635-43. PubMed ID: 21746806
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis pathways in cancer and cancer therapy.
Debatin KM
Cancer Immunol Immunother; 2004 Mar; 53(3):153-9. PubMed ID: 14749900
[TBL] [Abstract][Full Text] [Related]
15. Targeting apoptosis pathways in cancer therapy.
Fulda S; Debatin KM
Curr Cancer Drug Targets; 2004 Nov; 4(7):569-76. PubMed ID: 15578914
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
17. Low energy proton beam induces tumor cell apoptosis through reactive oxygen species and activation of caspases.
Lee KB; Lee JS; Park JW; Huh TL; Lee YM
Exp Mol Med; 2008 Feb; 40(1):118-29. PubMed ID: 18305405
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of apoptotic pathways in cancer.
Meiler J; Schuler M
Curr Drug Targets; 2006 Oct; 7(10):1361-9. PubMed ID: 17073598
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis pathways in neuroblastoma therapy.
Fulda S; Debatin KM
Cancer Lett; 2003 Jul; 197(1-2):131-5. PubMed ID: 12880972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
